Catalyst Pharmaceuticals (CPRX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Catalyst Pharmaceuticals Revenue Highlights

Latest Revenue (Y)

$398.20M

Latest Revenue (Q)

$122.71M

Main Segment (Y)

Product Revenue Net

Main Geography (Y)

CANADA

Catalyst Pharmaceuticals Revenue by Period

Catalyst Pharmaceuticals Revenue by Year

Date	Revenue	Change
2023-12-31	$398.20M	85.90%
2022-12-31	$214.20M	52.10%
2021-12-31	$140.83M	18.27%
2020-12-31	$119.07M	16.39%
2019-12-31	$102.31M	20361.27%
2018-12-31	$500.00K	100.00%
2017-12-31	-	100.00%
2016-12-31	-	100.00%
2015-12-31	-	100.00%
2014-12-31	-	100.00%
2013-12-31	-	100.00%
2012-12-31	-	100.00%
2011-12-31	-	-100.00%
2010-12-31	$488.96K	100.00%
2009-12-31	-	100.00%
2008-12-31	-	100.00%
2007-12-31	-	100.00%
2006-12-31	-	100.00%
2005-12-31	-	100.00%
2004-12-31	-	100.00%
2003-12-31	-	100.00%
2002-12-31	-	-

Catalyst Pharmaceuticals generated $398.20M in revenue during NA 2023, up 85.90% compared to the previous quarter, and up 79640.80% compared to the same period a year ago.

Catalyst Pharmaceuticals Revenue by Quarter

Date	Revenue	Change
2024-06-30	$122.71M	24.57%
2024-03-31	$98.51M	-10.91%
2023-12-31	$110.57M	7.67%
2023-09-30	$102.69M	3.12%
2023-06-30	$99.58M	16.65%
2023-03-31	$85.37M	40.50%
2022-12-31	$60.76M	6.14%
2022-09-30	$57.24M	7.78%
2022-06-30	$53.11M	23.26%
2022-03-31	$43.09M	12.48%
2021-12-31	$38.31M	6.55%
2021-09-30	$35.95M	-1.13%
2021-06-30	$36.37M	20.39%
2021-03-31	$30.20M	-2.61%
2020-12-31	$31.01M	5.79%
2020-09-30	$29.32M	-0.97%
2020-06-30	$29.60M	1.61%
2020-03-31	$29.14M	-3.27%
2019-12-31	$30.12M	-2.51%
2019-09-30	$30.90M	7.14%
2019-06-30	$28.84M	131.66%
2019-03-31	$12.45M	2389.69%
2018-12-31	$500.00K	100.00%
2018-09-30	-	100.00%
2018-06-30	-	100.00%
2018-03-31	-	100.00%
2017-12-31	-	100.00%
2017-09-30	-	100.00%
2017-06-30	-	100.00%
2017-03-31	-	100.00%
2016-12-31	-	100.00%
2016-09-30	-	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	100.00%
2012-12-31	-	100.00%
2012-09-30	-	100.00%
2012-06-30	-	100.00%
2012-03-31	-	100.00%
2011-12-31	-	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	-100.00%
2010-12-31	$488.96K	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	-

Catalyst Pharmaceuticals generated $122.71M in revenue during Q2 2024, up 24.57% compared to the previous quarter, and up 143.75% compared to the same period a year ago.

Catalyst Pharmaceuticals Revenue Breakdown

Catalyst Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 19
Product Revenue Net	$396.50M	$213.94M	$138.00M	-
License And Other Revenue	$1.70M	$265.00K	$2.84M	-
Product	-	-	-	$102.31M
Collaborative Arrangement Products Agreement	-	-	-	-

Catalyst Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product Revenue Net (99.57%), and License And Other Revenue (0.43%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
License And Other Revenue	$2.27M	$68.00K	$1.46M	$71.00K	$105.00K	$62.00K	$74.00K	$71.00K	$64.00K	$56.00K	-	-	-
Product Revenue Net	$126.42M	$98.44M	$109.10M	$102.62M	$99.48M	$85.30M	$60.68M	$57.17M	$53.05M	$43.03M	$38.27M	-	-
Product Revenue, Net	-	-	-	-	-	-	-	-	-	-	-	$35.89M	$33.64M

Catalyst Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product Revenue Net (98.24%), and License And Other Revenue (1.76%).

Catalyst Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 20
CANADA	$33.00K

Catalyst Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 20: CANADA (100.00%).

Quarterly Revenue by Country

Country	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21
License And Other Revenue	$105.00K	$62.00K	$74.00K	$71.00K	$64.00K	$56.00K	-	-	-
Product Revenue Net	$99.48M	$85.30M	$60.68M	$57.17M	$53.05M	$43.03M	$38.27M	-	-
Product Revenue, Net	-	-	-	-	-	-	-	$35.89M	$33.64M

Catalyst Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Jun 23: Product Revenue Net (99.89%), and License And Other Revenue (0.11%).

Catalyst Pharmaceuticals Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
INCY	Incyte	$3.70B	$962.99M
EXEL	Exelixis	$1.83B	$478.06M
SRPT	Sarepta Therapeutics	$1.24B	$362.93M
ACAD	ACADIA Pharmaceuticals	$726.44M	$250.40M
CPRX	Catalyst Pharmaceuticals	$398.20M	$122.71M
AXSM	Axsome Therapeutics	$270.60M	$87.17M
TGTX	TG Therapeutics	$233.66M	$83.88M
MREO	Mereo BioPharma Group	$10.00M	-
BTAI	BioXcel Therapeutics	$1.38M	$1.10M
XFOR	X4 Pharmaceuticals	-	$560.00K
VKTX	Viking Therapeutics	-	-
DAWN	Day One Biopharmaceuticals	-	$20.07M
INZY	Inozyme Pharma	-	-
MDGL	Madrigal Pharmaceuticals	-	$62.17M
TERN	Terns Pharmaceuticals	-	-
AKRO	Akero Therapeutics	-	-
HEPA	Hepion Pharmaceuticals	-	-

CPRX Revenue FAQ

What is Catalyst Pharmaceuticals’s yearly revenue?

Catalyst Pharmaceuticals's yearly revenue for 2023 was $398.2M, representing an increase of 85.90% compared to 2022. The company's yearly revenue for 2022 was $214.2M, representing an increase of 52.10% compared to 2021. CPRX's yearly revenue for 2021 was $140.83M, representing an increase of 18.27% compared to 2020.

What is Catalyst Pharmaceuticals’s quarterly revenue?

Catalyst Pharmaceuticals's quarterly revenue for Q2 2024 was $122.71M, a 24.57% increase from the previous quarter (Q1 2024), and a 23.23% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $98.51M, a -10.91% decrease from the previous quarter (Q4 2023), and a 15.40% increase year-over-year (Q1 2023). CPRX's quarterly revenue for Q4 2023 was $110.57M, a 7.67% increase from the previous quarter (Q3 2023), and a 81.98% increase year-over-year (Q4 2022).

What is Catalyst Pharmaceuticals’s revenue growth rate?

Catalyst Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 182.75%, and for the last 5 years (2019-2023) was 289.23%.

What are Catalyst Pharmaceuticals’s revenue streams?

Catalyst Pharmaceuticals's revenue streams in c 23 are Product Revenue Net, and License And Other Revenue. Product Revenue Net generated $396.5M in revenue, accounting 99.57% of the company's total revenue, up 85.34% year-over-year. License And Other Revenue generated $1.7M in revenue, accounting 0.43% of the company's total revenue, up 542.26% year-over-year.

What is Catalyst Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Catalyst Pharmaceuticals was Product Revenue Net. This segment made a revenue of $396.5M, representing 99.57% of the company's total revenue.